Literature DB >> 11122176

Biological behaviour and clinical implications of micrometastases.

M R Kell1, D C Winter, G C O'Sullivan, F Shanahan, H P Redmond.   

Abstract

BACKGROUND: The most important prognostic determinant in cancer is the identification of disseminated tumour burden (metastases). Micrometastases are microscopic (smaller than 2 mm) deposits of malignant cells that are segregated spatially from the primary tumour and depend on neovascular formation (angiogenesis) to propagate.
METHODS: The electronic literature (1966 to present) on micrometastases and their implications in malignant melanoma and epithelial cancers was reviewed.
RESULTS: Immunohistochemical techniques combined with serial sectioning offer the best accuracy for detection of nodal micrometastases. Molecular techniques should be reserved for blood samples or bone marrow aspirates. Detection of micrometastases in regional lymph nodes and/or bone marrow confers a poor prognosis in epithelial cancers. The concept of sentinel node biopsy combined with serial sectioning and dedicated screening for micrometastases may improve staging procedures. Strategies against angiogenesis may provide novel therapies to induce and maintain micrometastatic dormancy.
CONCLUSION: The concept of micrometastases has resulted in a paradigm shift in the staging of epithelial tumours and our overall understanding of malignant processes.

Entities:  

Mesh:

Year:  2000        PMID: 11122176     DOI: 10.1046/j.1365-2168.2000.01606.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  12 in total

1.  Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: Their clinical significance.

Authors:  John Griniatsos; Othon Michail; Nikoletta Dimitriou; Ioannis Karavokyros
Journal:  World J Gastrointest Oncol       Date:  2012-02-15

2.  Primary breast cancer features can predict additional lymph node involvement in patients with sentinel node micrometastases.

Authors:  P Carcoforo; U Maestroni; P Querzoli; S Lanzara; K Maravegias; L Feggi; G Soliani; E Basaglia
Journal:  World J Surg       Date:  2006-09       Impact factor: 3.352

3.  Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancer.

Authors:  Min Jung Jo; Ji Yeon Park; Joon Seon Song; Myeong-Cherl Kook; Keun Won Ryu; Soo-Jeong Cho; Jun Ho Lee; Byung-Ho Nam; Eun Kyung Hong; Il Ju Choi; Young-Woo Kim
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

4.  The prognostic significance of isolated tumor cells in the lymph nodes of gastric cancer patients.

Authors:  Takeo Fukagawa; Mitsuru Sasako; Seiji Ito; Hayao Nakanishi; Hisae Iinuma; Shoji Natsugoe; Hitoshi Katai; Tadakazu Shimoda
Journal:  Gastric Cancer       Date:  2010-09-05       Impact factor: 7.370

5.  Detection of disseminated tumor cells in nude mice with human gastric cancer.

Authors:  Bertram Illert; Christoph Otto; Arnulf Thiede; Wolfgang Timmermann
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

6.  A murine model of bone marrow micrometastasis in breast cancer.

Authors:  Barbara O'Kane Murphy; Shantaram Joshi; Anne Kessinger; Elizabeth Reed; J Graham Sharp
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

7.  Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma.

Authors:  Yuichiro Tojima; Masato Nagino; Tomoki Ebata; Katsuhiko Uesaka; Junichi Kamiya; Yuji Nimura
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

8.  Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival.

Authors:  Thomas R Cawthorn; Juan C Moreno; Moyez Dharsee; Danh Tran-Thanh; Suzanne Ackloo; Pei Hong Zhu; Girish Sardana; Jian Chen; Peter Kupchak; Lindsay M Jacks; Naomi A Miller; Bruce J Youngson; Vladimir Iakovlev; Cynthia J Guidos; Katherine A Vallis; Kenneth R Evans; David McCready; Wey L Leong; Susan J Done
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

9.  Sensitive, noninvasive detection of lymph node metastases.

Authors:  Mukesh G Harisinghani; Ralph Weissleder
Journal:  PLoS Med       Date:  2004-12-28       Impact factor: 11.069

10.  The presence of bone marrow cytokeratin-immunoreactive cells does not predict outcome in gastric cancer patients.

Authors:  G de Manzoni; G Pelosi; F Pavanel; A Di Leo; C Pedrazzani; E Durante; C Cordiano; F Pasini
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.